ERBB2 and colorectal cancer: In the third-generation (CD28.4-1BB.ζ) anti-HER2 CAR trial, a patient with pulmonary metastases of colorectal cancer received lymphodepleting chemotherapy followed by an intravenous dose of 1010 HER2-CAR T cells.